Abstract:Background Heart failure (HF) risk prediction models combine multivariable patient data to estimate an individual's risk of developing HF. By detecting at-risk and early-stage patients, models may facilitate earlier intervention to prevent or delay HF development. Previous systematic reviews were unable to recommend any existing prediction models for clinical use due to insufficient evidence and lack of guidelines on appraising study quality at their time of publication. Purpose To summarize the performance of risk prediction models for incident HF and identify models for further validation and potential clinical use. Methods We searched MEDLINE and EMBASE in June 2021 for English-language studies developing or validating HF risk prediction models. Studies were also retrieved from two previous systematic reviews. We narratively summarized model characteristics (e.g. model type, predictors used, prediction horizon) and study methodology (e.g. validation methods). Performance was assessed among all models validated in ≥ 1 cohort. For all models validated in ≥ 2 cohorts, we pooled discrimination measures using random-effects meta-analyses. Calibration was descriptively summarized based on individual study results from statistical tests and graph digitization of calibration plots. Study quality was assessed using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). Results Of 18,937 publications screened, 41 studies consisting of 120 prediction models were included. Twenty models were both derived and validated, 99 only derived, and 1 only validated. Risk of bias was rated as high in nearly all (94.7%) PROBAST assessments, mostly attributable to issues with analysis. Among 21 models validated in ≥ 1 cohort, most had moderate (61.9%, C-statistic 0.7 to <0.8) or high (23.8%, C-statistic 0.8 to <0.9) discrimination. In patients with low predicted risk (<10%), the calibration was adequate. Nine (42.9%) of these 21 models were presented as web-based calculators and five (23.8%) as points-based risk scores. Based on performance, number of validation cohorts, study risk of bias, and user friendliness, the Atherosclerosis Risk in Communities (ARIC), Multi-Ethnic Study of Atherosclerosis (MESA), Pooled Cohort equations to Prevent Heart Failure (PCP-HF), and Health ABC models emerged as the most promising risk scores for clinical practice. Conclusions Given their acceptable performance but high risk of bias, future studies should focus on the external validation of these models in studies of high methodological rigor. Models should be validated in a greater diversity of patient populations, particularly with respect to race. Impact analyses assessing how the clinical implementation of these models affects patient outcomes are also required prior to their routine use. Once validated, these models may help guide clinical decision making to prevent the onset of HF with early, aggressive risk factor modification.Discrimination in 21 validated modelsCharacteristics of recommended models

Neues Modell zur Risikovorhersage von Herz-Kreislauf-Erkrankungen

Neues KI-basiertes Prädiktionsmodell bei Niereninsuffizienz genauer als Standard

Computational and Human Intelligence Methods for Constructing Practical Risk Prediction Models: An Application to Cardio-Renal Outcomes in Non-Diabetic CKD Patients

Improving Cardiovascular Risk Prediction Through Machine Learning Modelling of Irregularly Repeated Electronic Health Records

An international model to predict recurrent cardiovascular disease

Risikovorhersagemodell für Endometriumkarzinom vorgestellt

A Cox-Based Risk Prediction Model for Early Detection of Cardiovascular Disease: Identification of Key Risk Factors for the Development of a 10-Year CVD Risk Prediction

Evaluating risk prediction models for adults with heart failure: A systematic literature review

Improving cardiovascular risk stratification with ECG-predicted risk factors in primary prevention

Guideline-Based Cardiovascular Risk Assessment Delivered by an mHealth App: Development Study

Actionable absolute risk prediction of atherosclerotic cardiovascular disease based on the UK Biobank

Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study

Herz und Blut: klonale Hämatopoese

Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions

Prediction models for cardiovascular disease risk in the general population: systematic review

Prognostic Modelling Studies of Coronary Heart Disease—A Systematic Review of Conventional and Genetic Risk Factor Studies

Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection

Risk prediction models for incident heart failure: a systematic review and meta-analysis

Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

Development of AI-Based Prediction of Heart Attack Risk as an Element of Preventive Medicine